Tag - BGBIO

Markets

HCW ups BerGenBio to buy on positive outlook for bemcentinib

H.C. Wainwright upgraded BerGenBio (OSLO:BGBIO) to “buy” from “neutral” with a price target of NOK30. The stock closed at NOK6.70 on Nov. 25. “As 2022 is coming to a close, we believe now is an opportune time to step...

November 28, 2022

Developments

BerGenBio presents bemcentinib data in NSCLC; receives FDA fast track

BerGenBio ASA (OSE:BGBIO) will deliver an e-poster presentation at the online Society for Immunotherapy of Cancer meeting with preclinical and clinical data suggesting that bemcentinib restored response to anti-PD-1...

November 9, 2021

Tag - BGBIO

HCW ups BerGenBio to buy on positive outlook for bemcentinib

BerGenBio presents bemcentinib data in NSCLC; receives FDA fast track

General

More